BYNFEZIA Pen
octreotide acetate
- Strength
- 2.5 mg/mL
- Form
- Injection
- Class
- Somatostatin Analog
Sun Pharmaceutical Industries, Inc.
Not stocked by us — reference only
octreotide acetate
Listed by Novartis Pharmaceuticals Corporation
| Dosage form | Injection, Solution |
|---|---|
| Route | Intravenous, Subcutaneous |
| Drug class | Somatostatin Analog |
| Approval route | NDA — original brand approval |
| NDC code | 0078-0181 |
| FDA application | NDA019667 |
| RxNorm concept | 207194 |
| Package sizes listed | 1 |
| Marketed since | October 1988 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
octreotide acetate
Sun Pharmaceutical Industries, Inc.
Not stocked by us — reference only
Octreotide
Chiesi USA, Inc.
Not stocked by us — reference only
Octreotide
Amryt Pharmaceuticals Designated Activity Compa…
Not stocked by us — reference only
OCTREOTIDE ACETATE
Fresenius Kabi USA, LLC
Not stocked by us — reference only
OCTREOTIDE ACETATE
Fresenius Kabi USA, LLC
Not stocked by us — reference only
OCTREOTIDE ACETATE
Fresenius Kabi USA, LLC
Not stocked by us — reference only
OCTREOTIDE ACETATE
Fresenius Kabi USA, LLC
Not stocked by us — reference only
Heritage Pharmaceuticals Inc. d/b/a Avet Pharma…
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.